Skip to content

Study on the efficacy of oropharyngeal probiotic DSM 34540 in relieving oral mucositis in patients with nasopharyngeal carcinoma undergoing simultaneous radiotherapy

Study on the efficacy of oropharyngeal probiotic DSM 34540 in relieving oral mucositis in patients with nasopharyngeal carcinoma undergoing simultaneous radiotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096223
Enrollment
Unknown
Registered
2025-01-20
Start date
2020-06-09
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucositis

Interventions

Intervention group:The research subjects in the probiotic group will receive a 7-week supply of research products and will be instructed to take a single lozenge four times a day during radiotherapy,

Sponsors

School of Medicine, Wuhan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with nasopharyngeal carcinoma (NPC) for the first time upon enrollment; 2. Ages 18-65; 3. Never received radiation therapy; 4. No active symptoms of respiratory infection; 5. Aseptic activity symptoms; 6. Activity symptoms without organ dysfunction; 7. Able to tolerate and complete this research; 8. Signed written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have received previous radiation therapy for the head and neck region 2. Patients with poor oral hygiene and/or severe periodontal disease 3. Active symptoms of respiratory infections during recruitment 4. Active symptoms of bacteremia 5. Active symptoms of organ dysfunction 6. Suffering from chronic respiratory diseases that may affect observation 7. Suffering from chronic oral mucositis and ulcers that may affect observation

Design outcomes

Primary

MeasureTime frame
The severity of oral mucosal inflammation;

Countries

China

Contacts

Public ContactWang Qiang

School of Medicine, Wuhan University of Science and Technology

wangqiang@wust.edu.cn+86 159 7150 9779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026